Tableaux’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$580K Sell
24,042
-3,214
-12% -$77.6K 0.24% 59
2026
Q2
$660K Sell
27,256
-3,050
-10% -$73.8K 0.28% 52
2026
Q1
$735K Buy
30,306
+10,271
+51% +$249K 0.36% 47
2025
Q4
$486K Sell
20,035
-1,647
-8% -$40K 0.34% 50
2025
Q3
$528K Buy
21,682
+1,103
+5% +$26.7K 0.21% 59
2025
Q2
$499K Buy
20,579
+4,523
+28% +$109K 0.29% 56
2025
Q1
$388K Buy
+16,056
New +$386K 0.28% 55

Other funds holding IBDS

Tableaux's IBDS Position: Q3 2026 in Review

Tableaux reduced its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 12% in Q3 2026, selling an estimated $77.6K and leaving 24,042 shares worth $580K. The position accounts for 0.24% of the portfolio, ranked #59.

Tableaux first reported a position in IBDS in Q1 2025 and has held it in 7 quarters since. The position peaked at $735K in Q1 2026. 152 funds tracked by Wall St. Rank hold IBDS as of Q3 2026.

  • Tableaux held 24,042 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $580K as of Q3 2026.
  • Tableaux sold 3,214 iShares iBonds Dec 2027 Term Corporate ETF shares in Q3 2026, an estimated $77.6K.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 0.24% of Tableaux's portfolio in Q3 2026, its #59 holding.
  • Tableaux first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q1 2025 and has held it in 7 quarters since.
  • Tableaux's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $735K in Q1 2026.
  • 152 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q3 2026.

Based on Tableaux's 13F filing for Q3 2026, filed 23 Oct 2026.